3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of SG301 for Renal AMR After TransplantationAntibody Mediated RejectionNot yet recruitingPhase 22026-08-17NCT07764627
Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior ImmunotherapyAdvanced Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingPhase 22026-05-26NCT05585580
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric CancerHER2-positive Gastric CancerActive, not recruitingPhase 22025-02-07NCT05586061